MITSUBISHI-ENG-PLASTICS
1.6.2021 03:02:05 CEST | Business Wire | Press release
Mitsubishi Engineering-Plastics Corporation (MEP), a world leader in high-performance polyacetal materials, has developed a new polyacetal resin (POM), the Iupital MA Series, that is compliant with medical standards.
The MA series is available in a range of standard, high-flow, high-rigidity, and low-friction grades, enabling greater design flexibility for medical devices and equipment, which are becoming smaller and lighter.
In particular, the low-friction grade MAL20 has greatly improved sliding performance with POM. In the past, combining POM parts would generate squeaking noise and friction, so designs would combine different materials in order to avoid these issues. MAL20 suppresses friction and wear, even when combined with ordinary POM, achieving quiet, smooth movement, which greatly improves comfort when used in medical devices.
In addition, with the MA series, we will offer a coloring masterbatch for color mixing. We support parts design not only in terms of physical characteristics, but also in terms of visual design.
MEP Vice President, Katsushige Hayashi, said the following. "These new materials, which exhibit a variety of excellent properties, will expand the range of designs, especially for medical devices and instruments, and contribute to improving their functionality. In particular, the sliding grade MAL20 eliminates the discomfort caused by noise and friction due to contact between POMs, providing users with comfort and ease of use."
The Iupital MA series meets the quality and regulatory requirements for medical materials, and is suitable for applications such as drug inhalers for COPD and asthma, injection devices such as insulin pens, and parts for medical devices.
Overview of Mitsubishi Engineering-Plastics Corporation
- Headquarters: Minato-ku, Tokyo
- Branches: Osaka Branch (Osaka, Osaka Prefecture), Nagoya Branch (Nagoya, Aichi Prefecture)
- Technical Base: Technical Center (Hiratsuka, Kanagawa Prefecture)
- President: Takashi Komaya
- Capital: 3 billion yen (50% invested by each of Mitsubishi Gas Chemical Company, Inc. and Mitsubishi Chemical Corporation)
Basic Information on the Iupital ™ MA Series
Features
- We offer a variety of grade groups in addition to the standard grades, including high flow, high rigidity, and low friction
- Masterbatch coloring available
- Worldwide sales and technical support
Grade Lineup
- MAS20 Standard: This is the grade with the most common physical properties and flowability
- MAS30 High flow: This grade has increased flowability. Suitable for precision molding
- MAH25 High rigidity: This grade has increased rigidity and strength. Suitable for making thinner walls and increasing strength
- MAL20 Low-friction: This grade has excellent sliding characteristics. It contributes to low-noise designs with low sliding resistance
Supported Standards, Etc.
- ISO10993-5, 10
- USP [87]
- USP [88] Class IV
- FDA Drug Master File
For data on physical properties, etc., please download it from our website, or contact our sales staff at the nearest head office, branch office, or local subsidiary.
Basic Physical Properties Charts
https://www.m-ep.co.jp/ja/eve/18-2.html (Japanese)
https://www.m-ep.co.jp/en/eve/18-2.html (English)
https://www.m-ep.co.jp/ch/eve/18-2.html (Chinese)
Sales Bases
https://www.m-ep.co.jp/company/kaigai.html (Japanese)
https://www.m-ep.co.jp/en/company/kaigai.html (English)
https://www.m-ep.co.jp/ch/company/kaigai.html (Chinese)
View source version on businesswire.com: https://www.businesswire.com/news/home/20210531005004/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting20.3.2026 15:00:00 CET | Press release
- New, late-breaking 54-week data for povorcitinib in hidradenitis suppurativa (STOP-HS1 & STOP-HS2) to be highlighted - Featured abstracts for ruxolitinib cream (Opzelura®) and povorcitinib include multiple ePosters in atopic dermatitis, hidradenitis suppurativa and vitiligo Incyte (Nasdaq:INCY) today announced that data from key programs in its Inflammation and Autoimmunity (IAI) franchise will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, to be held March 27 – 31, 2026, in Denver. “At AAD 2026, we are presenting late‑breaking 54-week results from the Phase 3 STOP‑HS program evaluating povorcitinib in hidradenitis suppurativa (HS),” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation and Autoimmunity, Incyte. “These data provide longer term evidence of the safety and efficacy of povorcitinib in HS patients and further strengthen the significant growth potential of our Inflammation and Autoimmunity franchise.” Details on key data presentation
MUSASHI JAPAN by TAIMATSU Launches “Road to Shogun” – A Journey Through Craftsmanship and Discovery20.3.2026 13:58:00 CET | Press release
Musashi Japan by TAIMATSU Co., Ltd., a contemporary Japanese knife brand rooted in the spirit of craftsmanship and cultural harmony, has announced its newest experiential campaign: “Road to Shogun.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320887471/en/ Designed as the brand’s most ambitious customer journey to date, the campaign invites visitors to explore participating Musashi Japan stores while discovering the traditions, culture and craftsmanship that inspire the brand. Inspired by the journey towards mastery, the experience encourages participants to progress through a series of ranks whilst visiting stores and unlocking rewards that celebrate elements of everyday Japanese culture. At Musashi Japan, craftsmanship is not only about the final product, but also about the path taken to achieve mastery. The Road to Shogun reflects this philosophy by guiding customers through a journey that mirrors the dedication, cu
Futur Delivers Strong Growth and Record Profit in 202520.3.2026 12:05:00 CET | Press release
In 2025, Futur added 21,000 new customers and the inflows amounted to 34 billion kronor. At the end of the year, the total savings capital was 252 billion kronor, an increase of 7% from the previous year and a new record level. "2025 was a record year for Futur. In a market characterized by sharp market fluctuations, Futur continued to invest, grow and deliver strong results. Behind this record performance is stable customer growth, strong inflows and cost discipline. Our close cooperation with over 60 partners gives customers the freedom to choose the asset management and advisory services that best suit them. The strategy of letting the customer choose is appreciated, which is reflected in us welcoming more than 21,000 new customers during the year", says Torgny Johansson, CEO of Futur. "We are optimistic about the future. Futur has great opportunities to continue growing in the coming years by developing innovative and efficient services for savings and pensions. I am proud of how a
Lyten to Establish a Lyten Industrial Hub in Poland20.3.2026 12:00:00 CET | Press release
Lyten announces the establishment of its next Lyten Industrial Hub in Gdańsk, Poland. The hub will bring together key manufacturing and digital resources to support energy infrastructure, the development of artificial intelligence, and the defense sector. In February 2026, Lyten announced the creation of the first Lyten Industrial Hub in Sweden, combining battery production operations there with a 1 GW AI data center campus. Lyten plans to complete its feasibility study by the end of 2026 to determine the full development plan Lyten, the supermaterial applications company and global leader in an energy storage, has announced its interest in establishing a Lyten Industrial Hub in Poland. In 2026, Lyten will conduct a feasibility study to assess manufacturing requirements for Lyten products, potential private and public partnerships, and the necessary energy and utility infrastructure. The industrial hub will be built around Lyten Dwa – the energy storage production plant and R&D center
PUMA Reveals Its Most Powerful International Football Kit Lineup yet on the Streets of New York City20.3.2026 08:00:00 CET | Press release
Reinforcing its status as a leading force in football kits at this summer’s competition, PUMA unveiled jerseys for 11 nations, including the most prominent African partner federations of any brand in the tournament, in a community-first celebration of football, music, and culture in New York City Global sports company PUMA unveiled its new national team kits for 11 nations with a street-level event at Domino Square in New York City, that placed football, music, food, and culture at the center stage in a celebration of the game. Rather than launching in a stadium setting or in a cinematic brand film, PUMA chose to reveal the kits in play, worn first by local community players from each nation on the streets of New York. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320641449/en/ Reinforcing its status as a leading force in football kits at this summer’s competition, PUMA unveiled jerseys for 11 nations, including the most
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
